| Confronting Cancer as a Community (NCT06063928) | University of Southern California | 2022-05-25 |
| Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities (NCT05447923) | Mayo Clinic | 2022-05-22 |
| Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors (NCT05215574) | NGM Biopharmaceuticals, Inc | 2022-03-31 |
| Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients (NCT05410977) | Mayo Clinic | 2022-03-30 |
| PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer (NCT05236972) | Sun Yat-sen University | 2022-01-01 |
| HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics (NCT04905082) | City of Hope Medical Center | 2021-12-30 |
| Audio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in Appalachia (NCT05810714) | Ohio State University Comprehensive Cancer Center | 2021-11-20 |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors (NCT04851119) | Children's Oncology Group | 2021-11-08 |
| Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis (NCT04767984) | Northwestern University | 2021-09-24 |
| Three Birds With One Stone (NCT05022511) | University of Aarhus | 2021-09-01 |
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy (NCT05083338) | M.D. Anderson Cancer Center | 2021-08-10 |
| Evaluation of a New Blood-based Test to Detect Colorectal Cancer and Its Precursors (NCT04980443) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-08-03 |
| Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy (NCT04868773) | University of California, Irvine | 2021-07-16 |
| Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC (NCT04890054) | OHSU Knight Cancer Institute | 2021-05-14 |
| mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases (NCT04781270) | Fudan University | 2021-04-15 |
| Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC (NCT04912765) | National Cancer Centre, Singapore | 2021-04-15 |
| Microsatellite Instability in Colorectal Cancers (NCT05162248) | Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | 2021-04-01 |
| Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer (NCT04812912) | Memorial Sloan Kettering Cancer Center | 2021-03-18 |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet (NCT04898842) | Royal Surrey County Hospital NHS Foundation Trust | 2021-03-02 |
| Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer (NCT05116696) | Clinical Centre of Serbia | 2021-03-01 |
| Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort Study (NCT04562727) | Ping Liang | 2021-03-01 |
| PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer (NCT04833387) | Sun Yat-sen University | 2021-01-01 |
| Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer (NCT04988191) | Peking University | 2020-12-24 |
| Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors (NCT04628780) | Pfizer | 2020-12-16 |
| Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization (NCT04208724) | Fred Hutchinson Cancer Center | 2020-11-18 |
| Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer (NCT04108481) | University of Iowa | 2020-10-05 |
| Role of Diet on the Microbiome of the Digestive System (NCT04666727) | M.D. Anderson Cancer Center | 2020-09-29 |
| Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers (NCT04430738) | Seagen, a wholly owned subsidiary of Pfizer | 2020-09-15 |
| VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC) (NCT04166383) | National Cancer Institute (NCI) | 2020-08-09 |
| Collection of Information to Better Understand Young Onset Colorectal Cancer (NCT04489238) | Memorial Sloan Kettering Cancer Center | 2020-07-22 |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC (NCT03732781) | Oncoinvent Solutions AS | 2020-05-27 |
| Study of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid Tumors (NCT04348916) | Oncorus, Inc. | 2020-05-20 |
| Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery (NCT04281667) | Helsinki University Central Hospital | 2020-03-18 |
| A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer (NCT04148378) | ProgenaBiome | 2020-03-02 |
| Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study (NCT04081779) | Fred Hutchinson Cancer Center | 2020-02-19 |
| A Community-Based Educational Intervention to Improve Colorectal Cancer Screening (NCT04392050) | Thomas Jefferson University | 2020-01-31 |
| Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial (NCT04490551) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-12-05 |
| Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups (NCT06090643) | Jonsson Comprehensive Cancer Center | 2019-11-01 |
| ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma (NCT04069455) | Zhejiang University | 2019-10-01 |
| Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening (NCT04607291) | Roswell Park Cancer Institute | 2019-09-01 |
| Microparticles in Peritoneal Carcinomatosis of Colorectal Origin (NCT03969784) | Assistance Publique Hopitaux De Marseille | 2019-09-01 |
| Home-based HIIT to Improve CRC Survivorship: Feasibility and Relationship With Novel Surrogate Biomarkers of CRC Recurrence (NCT04080414) | University of Utah | 2019-08-02 |
| Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer (NCT03592641) | National Cancer Institute (NCI) | 2019-07-25 |
| Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver (NCT03366155) | National Cancer Institute (NCI) | 2019-06-24 |
| A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (NCT03849469) | Xencor, Inc. | 2019-05-29 |
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398) | Xencor, Inc. | 2019-05-01 |
| The Problem of Colorectal Anastomosis Safety (NCT03958500) | Vilnius University | 2019-04-01 |
| ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer (NCT03822572) | Austrian Breast & Colorectal Cancer Study Group | 2019-02-14 |
| EXERCISING TOGETHER for Couples Coping With Cancer (NCT03630354) | OHSU Knight Cancer Institute | 2019-01-18 |
| Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting (NCT03804255) | ECOG-ACRIN Cancer Research Group | 2019-01-08 |
| A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment (NCT03428958) | NuCana plc | 2018-10-05 |
| Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers (NCT03300570) | National Cancer Institute (NCI) | 2018-07-27 |
| Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial (NCT03654131) | Rigshospitalet, Denmark | 2018-07-25 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer (NCT03597581) | Inspirna, Inc. | 2018-06-05 |
| Novel Stent Placement Technique for Intestinal Stenosis Assisted by an Ultrafine Endoscope (NCT04494919) | Ningbo No. 1 Hospital | 2018-06-01 |
| Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer (NCT03367611) | University of Aarhus | 2018-03-15 |
| Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients (NCT03152565) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2018-03-12 |
| CIRSE Registry for LifePearl Microspheres (NCT03086096) | Cardiovascular and Interventional Radiological Society of Europe | 2018-02-02 |
| An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread (NCT03377361) | Bristol-Myers Squibb | 2018-01-31 |
| Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers (NCT03332498) | H. Lee Moffitt Cancer Center and Research Institute | 2018-01-24 |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma (NCT02965703) | National Cancer Institute (NCI) | 2018-01-16 |
| Impact of the COVID-19 Pandemic on Oncologic Outcomes in Colorectal Cancer (NCT06638957) | In Ja Park | 2018-01-01 |
| Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases (NCT03717519) | Azienda Ospedaliera Universitaria Integrata Verona | 2018-01-01 |
| Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers (NCT03267524) | City of Hope Medical Center | 2017-11-09 |
| FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status (NCT03142516) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2017-10-31 |
| An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases. (NCT03029988) | Navidea Biopharmaceuticals | 2017-07-26 |
| The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery (NCT03064308) | University of Nottingham | 2017-06-26 |
| Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases (NCT02758951) | Koen Rovers | 2017-06-01 |
| Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study (NCT03546127) | Institut National de la Santé Et de la Recherche Médicale, France | 2017-05-23 |
| Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques (NCT03151564) | M.D. Anderson Cancer Center | 2017-05-09 |
| Educational Intervention - Improving Knowledge and Screening Rates for Colorectal Cancer (NCT03287453) | Ohio State University Comprehensive Cancer Center | 2017-04-08 |
| Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 (NCT03050814) | National Cancer Institute (NCI) | 2017-04-05 |
| First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors (NCT02729298) | Sumitomo Pharma America, Inc. | 2016-12-14 |
| Study Comparing Circular Stapler-assisted Colostomy vs Hand-stitching Colostomy of Colorectal Cancer Patients (NCT02652702) | Zhejiang University | 2016-12-01 |
| First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide (NCT03164486) | Julie L. Sutcliffe, Ph.D | 2016-11-01 |
| FOLFIRI Versus Irinotecan as Second-line Treatment in Metastatic Colorectal Cancer Patients (NCT02935764) | Fudan University | 2016-10-01 |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (NCT02669914) | Washington University School of Medicine | 2016-09-12 |
| Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors (NCT02611024) | PharmaMar | 2016-05-06 |
| Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer (NCT02577588) | National Center for Tumor Diseases, Heidelberg | 2016-05-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) (NCT02563002) | Merck Sharp & Dohme LLC | 2015-11-30 |
| CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor (NCT02617134) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2015-11-01 |
| Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) (NCT02460198) | Merck Sharp & Dohme LLC | 2015-08-25 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Predictive Factors for Anastomotic Leakage After Colorectal Surgery (NCT02347735) | Maastricht University Medical Center | 2015-08-01 |
| PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers (NCT02408406) | City of Hope Medical Center | 2015-07-07 |
| A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program (NCT02218801) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-05-01 |
| Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) (NCT02423954) | Western Regional Medical Center | 2015-04-01 |
| Patients With Rectal Cancer: a "Wait-and-see" Approach (NCT03001362) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2015-03-01 |
| A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor (NCT02365662) | AbbVie | 2015-01-09 |
| AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer (NCT02298946) | National Cancer Institute (NCI) | 2014-11-21 |
| Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia (NCT02243735) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-11-01 |
| Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults. (NCT02273141) | Norgine | 2014-11-01 |
| Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma (NCT02337946) | Takeda | 2014-10-16 |
| Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma (NCT02248805) | MacroGenics | 2014-10-01 |
| Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults. (NCT02273167) | Norgine | 2014-10-01 |
| Cancer Communication Within Hispanic Social Networks (NCT04444232) | Fred Hutchinson Cancer Center | 2014-09-09 |
| Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults (NCT02254486) | Norgine | 2014-09-01 |
| Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients (NCT02376452) | Fudan University | 2014-09-01 |